SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001615219-23-000044
Filing Date
2023-05-26
Accepted
2023-05-26 17:00:15
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 slrx-hcwresalesx3may2023v4.htm S-3 289813
2 EX-FILING FEES slrx-formsx3may2023resalexa.htm EX-FILING FEES 53416
3 EX-23.1 slrxforms-3may2023eyconsen.htm EX-23.1 2527
4 image_0a.jpg GRAPHIC 28105
5 EX-5.1 slrx-formsx3may2023resalex.htm EX-5.1 17796
6 image_0.jpg GRAPHIC 14681
7 image_1a.jpg GRAPHIC 197
  Complete submission text file 0001615219-23-000044.txt   423926
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-272249 | Film No.: 23970030
SIC: 2834 Pharmaceutical Preparations